Latest filing published 12 Dec 2006 for HOLLIS EDEN PHARMACEUTICALS INC /DE/, €15k.
No signal scores available.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brendan Mcdonnell appears in our data through filings on Hollis Eden Pharmaceuticals Inc /DE/ shares, published by SEC (Form 4). The record holds 6 filings, for trades running from 30 January 2006 to 12 December 2006.
The open-market side counts 2 purchases for €43k alongside 2 sales for €57k. Netting one side against the other leaves €14k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 option exercises.
Most recently, on 12 December 2006, the filings show an open-market purchase worth €15k in Hollis Eden Pharmaceuticals Inc /DE/. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations